Antibody Structure and Function: The Basis for Engineering Therapeutics
Структура и функции антител: основа создания терапевтических препаратов
2019-12-03
SCID: 54.1/cvkhb4qq
Discuss with AI
antibody engineeringantibody fragmentsantibody structure-function relationshipsbispecific antibodiestherapeutic biologics
Figures from the paper
Abstract (AI)
Antibodies and antibody-derived macromolecules have established themselves as the mainstay in protein-based therapeutic molecules (biologics). Our knowledge of the structure-function relationships of antibodies provides a platform for protein engineering that has been exploited to generate a wide range of biologics for a host of therapeutic indications. In this review, our basic understanding of the antibody structure is described along with how that knowledge has leveraged the engineering of antibody and antibody-related therapeutics having the appropriate antigen affinity, effector function, and biophysical properties. The platforms examined include the development of antibodies, antibody fragments, bispecific antibody, and antibody fusion products, whose efficacy and manufacturability can be improved via humanization, affinity modulation, and stability enhancement. We also review the design and selection of binding arms, and avidity modulation. Different strategies of preparing bispecific and multispecific molecules for an array of therapeutic applications are included.
Key Findings
1
Antibody structure–function relationships provide the foundation for engineering diverse protein-based therapeutics across numerous clinical indications.
2
Binding-arm design, selection, and avidity modulation enable the development of bispecific and multispecific molecules for varied therapeutic applications.
3
Engineering platforms encompass full antibodies, antibody fragments, bispecific antibodies, and antibody fusion products.
4
Humanization, affinity modulation, and stability enhancement improve the efficacy and manufacturability of antibodies and antibody-derived molecules.
5
Protein engineering can tune antibody antigen affinity, effector function, and biophysical properties to improve therapeutic performance.
Research Object
antibodies and antibody-derived macromolecules engineered as protein-based therapeutics
Research Subject
structure–function relationships and engineering of antibody-based therapeutics for antigen affinity, effector function, biophysical properties, efficacy, and manufacturability
Publication Details
Publication Date
2019-12-03
Journal
Publisher
ISSN
Cited by
728
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest